Genarp, Sweden

Jan Nilsson

USPTO Granted Patents = 23 

 

Average Co-Inventor Count = 2.2

ph-index = 9

Forward Citations = 140(Granted Patents)


Company Filing History:


Years Active: 2008-2020

Loading Chart...
Loading Chart...
23 patents (USPTO):Explore Patents

Title: Inventor Jan Nilsson: Innovations in Lupus Treatment

Introduction

Jan Nilsson, a notable inventor based in Genarp, Sweden, is recognized for his significant contributions to the field of medical therapeutics. With an impressive portfolio of 23 patents, Nilsson has dedicated his career to developing innovative methods for the treatment of autoimmune diseases, particularly systemic lupus erythematosus (SLE).

Latest Patents

Among his latest patents, Nilsson has focused on "Methods for treating systemic lupus erythematosus with an anti-apolipoprotein B antibody." These innovations describe peptides and antibodies that not only offer preventive and therapeutic treatments for mammals, including humans, against systemic lupus erythematosus but also provide diagnostic capabilities. The patents highlight methods to determine the presence or absence of related antibodies, which can indicate an increased or decreased risk of developing SLE and assist in grading, staging, and prognosis of the disease.

Career Highlights

Throughout his career, Jan Nilsson has worked with esteemed organizations such as Cedars-Sinai Medical Center and Forskarpatent I Syd. His involvement in these institutions has allowed him to collaborate on groundbreaking research and develop transformative medical treatments.

Collaborations

In pursuit of innovation, Nilsson has collaborated with distinguished professionals, including Prediman Krishan Shah and Roland Carlsson. These partnerships have played a crucial role in the advancement of his research and the successful patenting of his inventions.

Conclusion

In summary, Jan Nilsson is a visionary inventor whose contributions to the treatment of systemic lupus erythematosus exemplify the power of innovation in medicine. With a solid foundation of patents and collaborative efforts with fellow researchers, Nilsson continues to push the boundaries of therapeutic possibilities, aiming to improve the lives of those affected by autoimmune disorders.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…